Advertisement
open access
Medical Conferences
Conference Reports
Conference Proceedings
Disease Areas
Medical News
Multimedia
Podcast Channel
Videos
Webinar
About
2024 Medicom Conference Planning
Conference Proceedings
Home
>
Pulmonology
>
ATS 2019
ATS 2019
American Thoracic Society
17–22 May 2019,
Dallas, USA
Read the full Report (e-book)
Table of Contents
Colophon
Table of Contents
Featured articles
Letter from the Editor
Editor
Prof. Richard Dekhuijzen, Radboud University Medical Center, Nijmegen, the Netherlands
Interview with Prof. Christian Bergmann
Expert
Prof. Karl-Christian Bergmann, Charité, Berlin, Germany
Treatable Traits in Chronic Inflammatory Airway Disease: Back to Basics
Treatable traits in chronic inflammatory airway disease: back to basics
Presented By
Prof. Zuzana Diamant, Skåne University Hospital Lund, Sweden; Charles University and Thomayer Hospital, Czech Republic; and University Medical Center Groningen, the Netherlands
Critical Care Medicine
Distinguishing between 4 different subtypes of sepsis sets the stage for individualised treatment
Presented By
Prof. Christopher Seymour, University of Pittsburgh School of Medicine, USA
Stem cell therapy in acute respiratory distress syndrome improves 28-day mortality
Presented By
Dr Geoff Bellingan, University College London, United Kingdom
SPICE III trial: Early sedation with dexmedetomidine in critically ill patients
Presented By
Prof. Yahya Shehabi, Monash Health, Australia
SAATELLITE trial: Suvratoxumab prevents ventilator-associated Staphylococcus Aureus pneumonia in intensive care unit patients
Presented By
Prof. Bruno Franςois, University of Limoges, France
Sleep Medicine
Million-patient study reveals gaps in long-term adherence among various sub-populations
Presented By
Dr Jeff Armitstead, ResMed Science Center, Australia
Sleep apnoea severity has a non-linear relationship with acute myocardial infarction risk
Presented By
Dr Neomi Shah, Icahn School of Medicine at Mount Sinai, USA
Obstructive sleep apnoea affects morning spatial navigational memory processing in asymptomatic older individuals
Presented By
Dr Andrew Varga, Icahn School of Medicine at Mount Sinai, USA
Pulmonary Vascular Disease and Interstitial Lung Disease
Nintedanib reduces lung function decline in systemic sclerosis-associated ILD
Presented By
Prof. Oliver Distler, University Hospital Zurich, Switzerland
Pulmonary arterial hypertension: early treatment with selexipag most effective
Presented By
Prof. Sean Gaine, Mater Misericordiae University Hospital, Ireland
Long-term safety and efficacy of recombinant human pentraxin-2 in patients with idiopathic pulmonary fibrosis
Presented By
Prof. Ganesh Raghu’s, University of Washington, Seattle, USA
Infection
Dupilumab improves outcomes in patients with severe chronic rhinosinusitis with nasal polyps and comorbid asthma
Presented By
Dr Jorge Maspero, Fundación CIDEA, Argentina
Durability of culture conversion in patients receiving ALIS for treatment-refractory MAC lung disease
Presented By
Prof. David Griffith, University of Texas Health Science Center, USA
E-cigarette use disrupts normal immune response to viral infections, particularly in women
Presented By
Dr Meghan Rebuli, University of North Carolina at Chapel Hill, USA
Paediatric Pulmonary Medicine
Bacterial pneumonia predicts ongoing lung problems in infants hospitalised for acute respiratory failure
Presented By
Dr Garrett Keim, Children’s Hospital of Philadelphia, USA
Aspergillus and early cystic fibrosis lung disease: does it need to be treated?
Presented By
Dr Oded Breuer, Perth Children’s Hospital, Australia
COPD
CORTICO-COP trial: eosinophil-guided therapy reduces systemic corticosteroid exposure
Presented By
Dr Pradeesh Sivapalan, University of Copenhagen, Denmark
A randomised controlled trial of a smoking cessation smartphone application
Presented By
Dr Hiroki Tateno, Keio University School of Medicine, Japan
Benralizumab does not ameliorate COPD exacerbations (GALATHEA/TERRANOVA trials)
Presented By
Prof. Gerard Criner, Temple University, USA
Ensifentrine for COPD maintenance treatment
Presented By
Dr Dave Singh, University of Manchester, UK
Aclidinium bromide delays COPD exacerbation without increased MACE risk
Presented By
Prof. Kenneth Chapman, University of Toronto, Canada
Bench-to-Bedside (Pre-Clinical)
Human lung organoids to study foetal RSV infection
Presented By
Dr Terry Harford, Cleveland Clinic, USA
CRISPR/Cas9 genome editing therapy of hereditary pulmonary alveolar proteinosis
Presented By
Dr Kenjiro Shima, Cincinnati Children’s Hospital, USA
Cilia diagnostics in primary ciliary dyskinesia
Presented By
Prof. Heymut Omran, Munster University Hospital, Germany
Tuberous sclerosis complex 2 may be a novel target in pulmonary arterial hypertension therapy
Presented By
Dr Yuanjun Shen, University of Pittsburgh Medical Center, USA